reference/240287

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/240287

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Review
endingPage	403
issn	1179-1942 0114-5916
issueIdentifier	6
pageRange	381-403
publicationName	Drug Safety
startingPage	381
bibliographicCitation	Wagena EJ, Zeegers MP, van Schayck CP, Wouters EF. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. Drug Saf. 2003;26(6):381–403. doi: 10.2165/00002018-200326060-00002. PMID: 12688831.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a8da1a7bbbf2dd33d14102256c71140 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edaa9dcd66a978f80976a9cb6eac05ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_355e870810691a9a9ebd1bdeb745dc04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31d58ff586c5e9c11d80512c71eecd3f
date	200305
identifier	https://pubmed.ncbi.nlm.nih.gov/12688831 https://doi.org/10.2165/00002018-200326060-00002
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1481 https://portal.issn.org/resource/ISSN/0114-5916 https://portal.issn.org/resource/ISSN/1179-1942
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
discusses	http://id.nlm.nih.gov/mesh/M0025361 http://id.nlm.nih.gov/mesh/M0028000 http://id.nlm.nih.gov/mesh/M0014836
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261213 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261212 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404

Total number of triples: 33.